image
Sarepta Therapeutics, Inc. SRPT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 104.54
-4.19 %
$ 9.99 B
Market Cap
70.16
P/E
BALANCE SHEET
3.26 B ASSETS
4.35%
Growth Rates
1Year 4.35%
3Years 3.03%
5Years 14.73%
7Years 33.85%
10Years 27.32%
2.41 B LIABILITIES
-12.33%
Growth Rates
1Year -12.33%
3Years 2.66%
5Years 31.58%
7Years 60.57%
10Years 49.07%
859 M EQUITY
123.23%
Growth Rates
1Year 123.23%
3Years 4.10%
5Years -3.60%
7Years 14.32%
10Years 13.27%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Sarepta Therapeutics, Inc.
image
Current Assets 2.58 B
Cash & Short-Term Investments 1.68 B
Receivables 440 M
Other Current Assets 463 M
Non-Current Assets 685 M
Long-Term Investments 22.1 M
PP&E 357 M
Other Non-Current Assets 306 M
Current Liabilities 654 M
Accounts Payable 165 M
Short-Term Debt 141 M
Other Current Liabilities 348 M
Non-Current Liabilities 1.75 B
Long-Term Debt 1.27 B
Other Non-Current Liabilities 478 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995
ASSETS
Cash & Cash Equivalents 428.4 966.8 2 115.9 1 502.6 835.1 370.8 599.7 122.4 80.3 73.6 257.0 187.7 39.9 33.6 48.3 11.2 24.8 20.2 34.6 16.7 12.5 10.4 11.1 25.9 8.7 8.5 17.6 3.0 0.7
Short Term Investments 1 247.8 1 022.6 0 435.9 289.7 803.1 479.4 195.4 112.2 136.8 0 0 0 0 0.2 0.3 0.3 13.0 12.5 2.9 25.1 8.9 14.5 6.2 2.9 0 0 0 0.2
Receivables 439.7 259.7 171.6 135.5 90.9 49.0 29.5 5.2 4.0 2.4 3.5 4.7 3.6 3.2 2.1 5.0 2.9 51.5 K 1.2 0 0 0 0 0 0 0 0 0 0
Inventory 322.9 204.0 186.2 232.0 171.4 125.4 83.6 12.8 26.9 33.5 7.2 1 (3.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 140.5 108.1 224.0 179.1 81.9 77.8 36.5 37.6 28.1 35.0 10.3 1.5 1.6 1.0 1.3 0.3 0.8 0.7 0.4 0.7 0.8 1.1 1.9 1.0 100 K 0.5 100 K 0 0
Total Current Assets 2 579.3 2 557.9 2 604.1 2 485.2 1 468.9 1 426.2 1 228.6 373.5 224.5 247.8 270.8 193.9 45.2 37.8 51.3 17.0 28.7 33.9 48.7 20.2 38.4 20.4 27.5 33.1 11.7 9.0 17.7 3.0 0.9
PP&E 357.1 245.0 236.7 282.2 167.6 97.0 43.2 37.8 37.3 38.5 15.0 3.4 4.3 4.0 2.5 5.2 6.8 4.3 5.6 6.3 7.0 6.6 4.9 1.0 0.4 0.4 0.4 0.5 0.9
Intangible Assets 29.6 7.6 14.2 13.6 12.5 11.6 14.4 8.1 6.6 5.9 5.0 4.9 4.8 4.0 3.8 3.3 3.1 2.6 2.1 2.0 1.7 1.6 1.4 0.9 0.8 0.7 0.6 0 0.4
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 22.1 31.3 34.9 38.8 31.9 107.3 10.0 0.8 0.8 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 276.4 286.6 143.3 13.0 11.8 107.3 21.8 4.8 5.3 2.8 25 K 2.8 0.2 0.1 2.5 34.7 K 34.7 K 34.7 K 37.6 K 37.6 K 29.8 K 29.8 K 29.8 K 29.8 K 0 100 K 100 K 0.7 100 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 3 264.6 3 128.4 3 148.0 2 984.7 1 822.8 1 642.1 1 308.0 424.1 273.8 295.0 291.6 205.0 54.4 46.0 60.0 25.5 38.6 40.9 56.4 28.5 47.1 28.6 33.8 35.1 12.9 10.2 18.8 4.2 2.3
LIABILITIES
Accounts Payable 164.9 95.9 76.7 111.1 68.1 33.8 8.5 29.7 20.2 12.4 17.6 7.5 9.4 1.3 1.4 2.0 3.0 1.4 1.9 1.5 3.1 4.5 2.8 1.3 0.7 0.9 0.2 0.2 100 K
Short Term Debt 141.2 15.5 0 0 0 0 6.2 10.1 8.4 2.6 (9.5) 89 K 85 K 81 K 77 K 73.7 K 71.1 K 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 283.4 406.5 286.5 215.7 196.7 136.3 69.4 32.3 30.3 18.6 14.9 68.0 7.8 41.2 28.6 3.0 5.9 1.7 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.3 0.3 100 K 0.2
Total Current Liabilities 653.7 619.6 452.7 416.0 264.8 173.7 88.3 75.4 62.3 36.9 36.0 78.9 20.6 45.9 33.5 7.3 9.8 3.2 2.7 2.2 3.8 5.1 3.3 1.7 1.0 1.2 0.5 0.3 0.3
Long Term Debt 1 273.5 1 601.9 1 138.4 1 072.9 729.6 420.6 424.9 6.0 15.0 3.7 1.6 1.7 1.8 1.8 1.9 2.0 2.1 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 41.1 36.9 54.6 70.6 10.2 15.6 5.5 5.9 6.2 6.8 6.8 0.8 1.0 1.1 1.0 0.5 0.4 0 0 0 0 0 0 0 0 0 0 3.1 0
Total Liabilities 2 405.2 2 743.4 2 220.0 2 223.0 1 004.6 609.8 518.7 87.4 83.4 47.4 44.4 81.3 23.4 48.8 36.4 9.8 12.3 3.2 2.7 2.2 3.8 5.1 3.3 1.7 1.0 1.2 0.5 3.4 0.3
EQUITY
Common Stock 9 K 9 K 9 K 8 K 8 K 7 K 6 K 5 K 5 K 4 K 4 K 3 K 13 K 11 K 11 K 7.11 K 6.44 K 5.32 K 5.12 K 3.61 K 3.45 K 2.66 K 2.32 K 2.15 K 0 0 0 0 3.1
Retained Earnings (4 446.2) (3 910.2) (3 206.7) (2 848.1) (2 294.0) (1 578.9) (1 217.0) (1 166.3) (899.1) (679.0) (543.2) (431.3) (310.0) (307.6) (275.5) (250.3) (226.4) (203.7) (172.6) (156.0) (131.2) (116.6) (87.2) (60.3) (51.1) (42.8) (16.0) (12.4) (10.3)
Other Accumulative Comprehensive Income/Loss 0.9 (1.7) 20 K 3 K 50 K 99 K (0.4) (0.1) (0.1) 95 K (17.3) (16.7) (15.8) (15.0) (14.0) (12.9) (11.8) 18.4 K 13 K (0.1) (0.3) 0.7 1.0 (11.7) (2.5) (2.4) (2.3) (1.9) 100 K
Total Equity 859.3 384.9 928.0 761.8 818.2 1 032.3 789.2 336.7 190.3 247.7 247.2 123.7 31.0 (2.8) 23.6 15.7 26.4 37.7 53.7 26.3 43.4 23.5 30.5 33.4 11.9 9.0 18.3 0.8 2.1
Total Liabilities and Equity 3 264.6 3 128.4 3 148.0 2 984.7 1 822.8 1 642.1 1 308.0 424.1 273.8 295.0 291.6 205.0 54.4 46.0 60.0 25.5 38.6 40.9 56.4 28.5 47.1 28.6 33.8 35.1 12.9 10.2 18.8 4.2 2.4
SHARES OUTSTANDING
Common Shares Outstanding 92.4 87.6 81.3 78.0 73.6 66.2 58.8 48.7 42.3 40.0 33.8 23.6 21.6 18.5 15.5 11.6 9.0 8.8 7.4 6.0 5.0 4.3 3.7 3.1 2.2 2.0 1.7 1.4 1.2